For instance, in breast cancer cells, MARCH8 ubiquitinates STAT3 and CD44, suppressing tumor metastasis (Chen et al, 2021), while in hepatocellular carcinoma, MARCH8 induces degradation of PTEN thereby promoting malignancy (Xu et al, 2023). Here, CD44 is linked to hepatocellular carcinoma.